Gilles Dadaglio

Title: The Innovative Contributions of Gilles Dadaglio

Introduction

Gilles Dadaglio is a notable inventor based in Chatillen, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of immunogenic compositions.

Latest Patents

Gilles Dadaglio holds 1 patent related to an immunogenic composition that comprises a recombinant protein, specifically aCyaA or a fragment thereof, along with a peptide corresponding to a tumor antigen. This composition is designed as a cancer treatment, particularly for melanoma. The therapeutic composition includes epitopes from the HLA*0201 epitope, which features Tyr or GnT-V, and is present in the recombinant proteins CyaA-E5-Tyr and CyaA-E5-GnT-V.

Career Highlights

Throughout his career, Gilles Dadaglio has worked with prestigious institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His work has focused on developing innovative solutions for cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Gilles has collaborated with esteemed colleagues, including Claude Leclerc and Daniel Ladant, further enhancing the impact of his research in the scientific community.

Conclusion

Gilles Dadaglio's contributions to cancer treatment through his innovative patent and collaborations with leading institutions and professionals highlight his significant role in the field of medical research. His work continues to inspire advancements in immunotherapy and cancer treatment.